The Latest Breaking News from ABT

Abbott Laboratories' Q4 earnings report and stock performance analysis, highlighting limited growth potential.

The medical sector is poised for substantial gains this year, fueled by rising cases of chronic diseases and swift technological progress. In light of this, let’s analyze the fundamentals of three medical stocks: Abbott Laboratories (ABT), Agilent Technologies (A), and Viemed Healthcare (VMD). Read on….

America’s national ballet company has returned to China for the first time in a decade, the latest sign that the strained U.S.-China relations are beginning to improve

Despite Audi withdrawing factory backing from GT3 racing and reducing its involvement to basic supply of spare parts, Abt will continue to field a pair of R8 LMS GT3s in the German category in 2024.

“What I’m really looking forward to is fighting for the championship after season 10. This is where I want to get back to and although nothing is 100% certain, I am very certain that Abt will make the best decision.”

December S&P 500 futures (ESZ23) are trending down -0.45% this morning as uncertainties lingered in the Middle East, and investors weighed the possibility of further rate hikes by the Federal Reserve while eagerly awaiting earnings results from U.S. heavyweights Tesla and Netflix.

December S&P 500 futures (ESZ23) are trending down -0.34% this morning as uncertainties lingered in the Middle East, and investors weighed the possibility of further rate hikes by the Federal Reserve while eagerly awaiting earnings results from U.S. heavyweights Tesla and Netflix.

Considering Abbott Laboratories' (ABT) recent strategic collaborations and acquisitions to boost the company’s long-term growth, could the stock be a compelling buy as we approach its fiscal third-quarter earnings release? Let's find out.

Abt has been associated with Audi in the DTM ever since the series was revived in 2000 and has won five titles with the revered marque during this period.